E2F2 and central nervous system cancer: The latest study has elucidated that E2F2 drives glioma’s progression via the PI3K/Akt pathway in a 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 4 (PFKFB4)-dependent manner [29].